Search filters

List of works by William E Boden

A PROMISE Fulfilled That Quality-of-Life Assessments Afford Incremental Value to Coronary Artery Disease Management

scientific article published on 27 April 2016

A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

scientific article published in September 2005

An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial

scientific article (publication date: September 2007)

An evidence-based score to detect prevalent peripheral artery disease (PAD)

article

Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial

scientific article published in November 2011

Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review.

scientific article published on 04 August 2015

Antianginal Therapy for Stable Ischemic Heart Disease

scientific article published on January 2017

Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes

article

As REGARDS treatment goal attainment compared with COURAGE: the perfect should not be the enemy of the good.

scientific article published on 26 February 2014

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial

scientific article

Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial

scientific article published on 30 March 2020

Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease

scientific article published on 01 August 2019

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial

scientific article published on 13 November 2019

Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention

scientific article published on 01 August 2012

Cardiovascular outcomes during extended follow-up of the AIM-HIGH trial cohort

scientific article published on 25 July 2018

Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function

scientific article published in 2022

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

scientific article (publication date: 20 April 2006)

Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging

scientific article

Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the What Is the Optimal Method for Ischemia Evalu

scientific article

Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management

scientific article published in 2021

Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled Trials

scientific article published in 2022

Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?

scientific article published on 21 December 2015

Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients

scientific article published in September 2008

Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).

scientific article published on 5 January 2010

DAYS ALIVE OUT OF HOSPITAL WITH INITIAL INVASIVE VS CONSERVATIVE MANAGEMENT IN THE ISCHEMIA TRIAL

scientific article published in 2021

Deferral of PCI, a safe strategy in diabetic patients with chronic coronary syndromes

scientific article published on 28 July 2020

Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424

scientific article (publication date: June 2006)

Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review

scientific article published on 28 December 2016

Diagnostic Implications in the Aftermath of the ISCHEMIA Trial

scientific article published on 12 February 2020

Do major cardiovascular outcomes in patients with stable ischemic heart disease in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial differ by healthcare system?

scientific article published on 27 July 2010

Does the potential overuse of routine post PCI stress testing and revascularization inspire courage to embrace more evidence-based decision making?

scientific article published in January 2013

Early Revascularization in NSTE-ACS: Insights From the ICTUS Long-Term Follow-Up

scientific article published in September 2017

Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

article

Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease

scientific article published on 01 February 2019

Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease

scientific article published on November 2015

Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).

scientific article published on 31 August 2015

Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial

scientific article published on 4 February 2015

Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients

scientific article

Effectiveness of percutaneous coronary intervention in patients with silent myocardial ischemia (post hoc analysis of the COURAGE trial).

scientific article published in April 2012

Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.

scientific article published on 29 March 2016

Effects of Extended-Release Niacin on Quartile Lp-PLA2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial

scientific article published on 26 May 2019

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes

scientific article published in July 2009

Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel

scientific article published on 12 July 2013

Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review

scientific article published on 01 November 2020

Evaluation of the stable coronary artery disease patient: anatomy trumps physiology

scientific article published on 15 August 2014

Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative

scientific article

Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial

scientific article published on 23 July 2013

External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction

scientific article published on 16 March 2018

Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial

scientific article published on 09 July 2013

Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.

scientific article published in September 2006

HDL hypothesis: where do we stand now?

scientific article published on April 2014

Haptoglobin Genotype as a Determinant of Benefit or Harm From Niacin for Participants With Diabetes

scientific article published on 01 May 2016

Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).

scientific article published on 3 September 2013

Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease

scientific article published on 30 March 2020

Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Corona

scientific article

High-density lipoproteins: a consensus statement from the National Lipid Association

scientific article published on 11 August 2013

Historical Milestones in the Management of Stable Coronary Artery Disease over the Last Half Century

scientific article published on 28 June 2018

INTERNATIONAL COMPARISONS OF HEALTH STATUS OUTCOMES IN PATIENTS UNDERGOING INITIAL INVASIVE VERSUS CONSERVATIVE MANAGEMENT FOR CHRONIC CORONARY DISEASE: INSIGHTS FROM THE ISCHEMIA TRIAL

scientific article published in 2023

Impact of adding ezetimibe to statin to achieve low-density lipoprotein cholesterol goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] trial).

scientific article published on 25 March 2013

Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial

scientific article published on 28 August 2009

Impact of expanded FDA indication for icosapent ethyl on enhanced cardiovascular residual risk reduction

scientific article published on 22 September 2020

Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial

scientific article published on 01 July 2011

Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial)

scientific article published on 16 April 2009

Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization

scientific article published on 01 November 2020

Initial Invasive or Conservative Strategy for Stable Coronary Disease

scientific article published on 30 March 2020

Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial

scientific article published in March 2010

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design

article

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches–Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design

article

International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Commi

scholarly article

Is HPS2-THRIVE the death knell for niacin?

scientific article published on 30 January 2015

Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?

scientific article published on 01 February 2011

Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists

scientific article published on 01 December 2011

Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug E

scientific article published on 21 August 2013

Making Cardiovascular Care More Responsive to Societal Needs

scientific article published on 7 August 2017

Management of Coronary Disease in Patients with Advanced Kidney Disease

scientific article published on 30 March 2020

Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise

scientific article

Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease

scientific article

Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial

scientific article published on 5 July 2017

Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons

scientific article published on 03 December 2020

Myocardial ischemia: From disease to syndrome

scientific article published on 26 April 2020

Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon

scientific article

Optimal management of persistent mixed dyslipidemia after statin initiation warrants combination therapy

scientific article published on 01 December 2009

Optimal medical therapy vs. revascularization on long-term LV function

scientific article published on 20 August 2013

Optimal medical therapy with or without PCI for stable coronary disease

scientific article

Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation)

scientific article published on 01 September 2009

Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial

scientific article

Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy

scientific article published on 11 February 2008

PCSK9 Inhibition for Therapeutic Decision-Making: Assessing the Value

scientific article published on 01 May 2020

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

scientific article (publication date: 15 May 2007)

Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes

scientific article

Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals

scientific article published on 14 April 2008

Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials

scientific article

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization ⬇️

scientific article published on August 25, 2012

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial

scientific article published in The Lancet

Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia

scientific article

Predictors of Initial Revascularization Versus Medical Therapy Alone in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing an Invasive Strategy

scientific article published in July 2016

Prior Cardiovascular Interventions Are Not Associated With Worsened Clinical Outcomes in Patients With Symptomatic Atherothrombosis

scientific article published on 01 September 2010

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

scientific article published on 23 December 2019

Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial

scientific article published on 2 August 2013

Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial

scientific article

Reconsidering the Gatekeeper Paradigm for Percutaneous Coronary Intervention in Stable Coronary Disease Management

scientific article

Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention

scientific article

Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry

scientific article published in September 2009

Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry).

scientific article

Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial

scientific article published on 12 January 2018

Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial

scientific article published on 9 March 2018

Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).

scientific article published on 31 July 2013

Reperfusion Paradox in ST-Segment Elevation Myocardial Infarction

scientific article published on September 20, 2011

Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.

scientific article published on 21 September 2015

Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease

scientific article published on 08 June 2020

Role of dual antiplatelet therapy in symptomatic patients with established vascular disease: putting the CHARISMA trial into therapeutic perspective

scientific article published in June 2010

Role of short-acting nitroglycerin in the management of ischemic heart disease

scientific article

Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials

scientific article published on June 2005

Safety profile of extended-release niacin in the AIM-HIGH trial

scientific article

Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections

scientific article published on 22 April 2015

Successful percutaneous coronary intervention significantly improves coronary sinus blood flow as assessed by transthoracic echocardiography

scientific article published on 7 November 2017

Survival After Invasive or Conservative Management of Stable Coronary Disease

scientific article published in 2023

Technology-Enabled Clinical Trials: Transforming Medical Evidence Generation

scientific article published on 21 October 2019

Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease

scientific article published on 20 March 2020

The Editor's Roundtable: Role of Percutaneous Coronary Intervention and Drug-Eluting Stents in Patients With Stable Coronary Heart Disease ⬇️

scientific article published on November 15, 2011

The Role of Nitrates in the Management of Stable Ischemic Heart Disease: A Review of the Current Evidence and Guidelines

scientific article published on January 2017

The Two-Edged Sword of Shared Clinical Decision-Making in the Post-ISCHEMIA World of Stable Coronary Artery Disease Management: Clinical Commentary on "It Happened So Fast … I Guess, Yes, I Was Lucky"

scientific article published on 17 February 2020

The continued importance of optimal medical therapy with or without revascularization in diabetic patients with coronary artery disease

scientific article published on 10 April 2015

The corrected values for duration and frequency of angina at baseline in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial

scientific article published on 01 November 2007

The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina

scientific article published on 08 February 2011

The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial

scientific article published on 17 November 2006

The therapeutic role of niacin in dyslipidemia management

scientific article

TpTe and TpTe/QT: novel markers to predict sudden cardiac death in ESRD?

scientific article published on 16 August 2018

Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes

scientific article published on 05 March 2008

Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management

scientific article published on 20 June 2018

Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery

scientific article published on April 2017

Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy.

scientific article

Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

scientific article published in November 2004

Why Optimal Medical Therapy Should Be a Universal Standard of Care

scientific article published in August 2015

Will COMPASS Point to a New Direction in Thrombotic Risk Reduction in Patients With Stable Cardiovascular Disease?

scientific article published on 01 August 2018

β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial

scientific article published on 30 September 2014

Paulina is supported by:

About Paulina

Help